Evidence map›Paper›PMID 34943781›Full record

ReviewCells2021

Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside.

Stephanie Cherqui

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. The molecular architecture of tunneling nanotubes.bioRxiv : the preprint server for biology · 2026
    Article
  2. Cystinosin regulates NaEMBO reports · 2026
    Article
  3. Article
  4. Long-term outcomes in nephropathic cystinosis: a review.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  5. Cystinosis and Cellular Energy Failure: Mitochondria at the Crossroads.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Clinical hematopoietic stem cell-based gene therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  8. Review
  9. Article
  10. Cystinosin is involved in NabioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Stephanie CherquiDepartment of Pediatrics, Division of Genetics, University of California, La Jolla, San Diego, CA 92093, USA.
University of California, San Diego · US

Funding

Lentiviral-transduced hematopoictic stem cell transplantation for cystinosisR01DK090058 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERQUI, STEPHANIE · 2011 to 2019
$2.7M
Hematopoietic Stem Cell Gene Therapy for Friedreich's ataxiaR01NS108965 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERQUI, STEPHANIE · 2018 to 2022
$1.7M
Toxicology studies for gene-modified stem cell transplantation for cystinosisR01DK099338 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERQUI, STEPHANIE · 2013 to 2014
$539k
NIDDK NIH HHS R01 DK090058NIDDK NIH HHS R01 DK099338NINDS NIH HHS R01 NS108965
6 · The paper itself

Abstract

Cystinosis is an autosomal recessive metabolic disease that belongs to the family of lysosomal storage disorders. The gene involved is the

Indexed as

Genetic TherapyHematopoietic Stem Cell TransplantationAmino Acid Transport Systems, NeutralAnimalsCystinosisHumansKidneyLysosomesTransplantation, HomologousAmino Acid Transport Systems, NeutralCTNS protein, humanCD34+ hematopoietic stem and progenitor cellsclinical trialcystinosisgene therapyinvestigational new drug applicationpre-clinical studies

Identifiers

PMID34943781
PMCPMC8699556
OpenAlexW3215937272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.